Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say

Why did US retail sales drop sharply in May? How will Kraft Heinz's dye removal impact consumers? What caused the recent spike in oil prices? Why is Trump urging evacuation of Tehran now? How will new US stablecoin regulations affect crypto? What led to 23andMe's recent data breach fine? Why is JetBlue implementing more cost cuts in 2025?

Eli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies say

reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-gene-editing-therapy-developer-verve-therapeutics-up-13-2025-06-17

This story appeared on reuters.com, 2025-06-17 10:55:12.107000.

The Entire Business World on a Single Page. Free to Use →